Mission, Canada

Ian MacLachlan

USPTO Granted Patents = 50 

 

Average Co-Inventor Count = 3.6

ph-index = 28

Forward Citations = 3,744(Granted Patents)

Forward Citations (Not Self Cited) = 3,371(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Mission, CA (US) (2015)
  • Burnaby, CA (2015)
  • Vancouver, CA (2005 - 2022)
  • Mission, CA (2010 - 2024)

Company Filing History:


Years Active: 2005-2024

Loading Chart...
Loading Chart...
50 patents (USPTO):Explore Patents

Title: The Innovative Work of Ian MacLachlan in Mission, CA

Introduction

Ian MacLachlan, based in Mission, California, is a prominent inventor who holds an impressive portfolio of 50 patents. His contributions to the field of pharmaceutical formulations, particularly in lipid-based delivery systems for therapeutic agents, have positioned him as a crucial figure in the fight against diseases, including cancer.

Latest Patents

Among his latest groundbreaking inventions are lipid formulations designed for the delivery of therapeutic agents. These innovations present novel, serum-stable lipid particles that encapsulate one or more active agents, specifically aimed at improving treatment methods. One highlighted invention includes serum-stable nucleic acid-lipid particles (SNALP), which contain nucleic acids, such as interfering RNA molecules. This method of delivery is particularly significant for treating cancer, as the formulation includes tumor-directed lipid particles that can preferentially target solid tumors. By concentrating the therapeutic payload within cancerous cells while sparing non-cancerous cells, these innovations may enhance treatment efficacy and reduce side effects.

Career Highlights

Ian has made significant impacts in his field through collaborations with notable companies such as Protiva Biotherapeutics, Inc. and Arbutus Biopharma Corporation. His work not only underscores his expertise in biotherapeutic innovations but also demonstrates his commitment to advancing medical treatments through inventive solutions.

Collaborations

Throughout his career, Ian has worked alongside distinguished colleagues, including Lorne Ralph Palmer and Adam Judge. Their collaborations have further enriched the innovative landscape of therapeutic delivery, fostering an environment where cutting-edge ideas can flourish.

Conclusion

With an exemplary record of innovation and a commitment to improving therapeutic delivery systems, Ian MacLachlan remains a pivotal figure in his field. His advancements have the potential to transform treatment paradigms, particularly for cancer patients, showcasing the vital role of inventors in driving medical progress. As he continues to develop new formulations, the future looks promising for his contributions to the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…